Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects (Q38447305)
Jump to navigation
Jump to search
scientific article published on 31 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects |
scientific article published on 31 July 2013 |
Statements
1 reference
Effects of LX4211, a dual sodium-dependent glucose cotransporters 1 and 2 inhibitor, on postprandial glucose, insulin, glucagon-like peptide 1, and peptide tyrosine tyrosine in a dose-timing study in healthy subjects (English)
1 reference
Brian Zambrowicz
1 reference
Ike Ogbaa
1 reference
Kenny Frazier
1 reference
Phillip Banks
1 reference
Anne Turnage
1 reference
Joel Freiman
1 reference
Kristi A Boehm
1 reference
Dennis Ruff
1 reference
David Powell
1 reference
Arthur Sands
1 reference
31 July 2013
1 reference
1 reference
1162-1173.e8
1 reference
Identifiers
1 reference